Aberdeen Asset Management (LON:ADN) Rating
They currently have a GBX 370.00 PT on Aberdeen Asset Management (LON:ADN). Credit Suisse’s target would suggest a potential upside of 15.37% from the company’s close price. This was released in a research report on 30 November.
Out of 15 analysts covering Aberdeen Asset Management PLC (LON:ADN), 2 rate it “Buy”, 3 “Sell”, while 10 “Hold”. This means 13% are positive. GBX 520 is the highest target while GBX 270 is the lowest. The GBX 370 average target is 15.56% above today’s (GBX 320.18) stock price. Aberdeen Asset Management PLC was the topic in 34 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Numis Securities maintained the stock on November 27 with “Hold” rating. Barclays Capital maintained it with “Equal Weight” rating and GBX 350 target price in a November 11 report. J.P. Morgan maintained the shares of ADN in a report on November 23 with “Neutral” rating. Credit Suisse maintained the firm’s rating on November 10. Credit Suisse has “Neutral” rating and GBX 370 price target. Finally, BNP Paribas maintained the stock with “Underperform” rating in a November 19 report.
About 4.11M shares traded hands or 16.76% up from the average. Aberdeen Asset Management plc (LON:ADN) has declined 27.70% since May 1, 2015 and is downtrending. It has underperformed by 26.81% the S&P500.
Aberdeen Asset Management PLC is United Kingdom asset management company. The company has a market cap of 4.22 billion GBP. The Firm manages assets for both institutional and retail clients. It has 14.07 P/E ratio. The firm invests across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Aberdeen Asset Management - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.